EP Patent

EP0624376A1 — Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci

Assigned to Wyeth Holdings LLC · Expires 1994-11-17 · 31y expired

What this patent protects

Described herein is a method for removing toxic lipooligosaccharide (LOS) from outer membranes of Gram-negative cocci, such as Neisseria meningitidis . LOS-depleted outer membranes and LOS-depleted soluble outer membrane proteins can be prepared, which are able to elicit bacteri…

USPTO Abstract

Described herein is a method for removing toxic lipooligosaccharide (LOS) from outer membranes of Gram-negative cocci, such as Neisseria meningitidis . LOS-depleted outer membranes and LOS-depleted soluble outer membrane proteins can be prepared, which are able to elicit bactericidal antibodies against homologous strains of bacteria. Vaccines and other uses of the preparations are further described.

Drugs covered by this patent

Patent Metadata

Patent number
EP0624376A1
Jurisdiction
EP
Classification
—
Expires
1994-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth Holdings LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.